Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial.
Document Type
Journal Article
Publication Date
2-27-2020
Journal
JAMA Oncology
DOI
10.1001/jamaoncol.2019.6722
APA Citation
Stratton, P., Battiwalla, M., Tian, X., Abdelazim, S., Baird, K., Barrett, J., Cantilena, C. R., Childs, R. W., DeJesus, J., Fitzhugh, C., Fowler, D., Gea-Banacloche, J., Gress, R. E., Hickstein, D., Hsieh, M., Ito, S., Kemp, T. J., Khachikyan, I., Merideth, M. A., Pavletic, S. Z., Quint, W., Schiffman, M., Scrivani, C., Shanis, D., Shenoy, A. G., Struijk, L., Tisdale, J. F., Wagner, S., Williams, K. M., Yu, Q., Wood, L. V., & Pinto, L. A. (2020). Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial.. JAMA Oncology, (). http://dx.doi.org/10.1001/jamaoncol.2019.6722
Peer Reviewed
1
Comments
Online ahead of print